← SynDRA
GSK-2334470
SynDRA canonical compound SYN0087442 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PDPK1 |
|---|
| Mechanism of action | Pyruvate dehydrogenase kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Pyruvate dehydrogenase kinase inhibitor
- phosphoinositide dependent kinase inhibitor
- PDPK1 INHIBITOR
Cross-references
Synonyms
- GSK-470
- GSK2334470
- PDK1 inhibitors, GlaxoSmithKline
- QB5BF4GJ87
- RefChem:144548
- C25H34N8O
- QLPHOXTXAKOFMU-WBVHZDCISA-N
- MFCD21608525
- UNII-QB5BF4GJ87
- MLS006011255
- GTPL8008
- orb1305621
- SCHEMBL1317022
- PDK1 inhibitor GS2334470
- SCHEMBL29410282
- CHEBI:91465
- GLXC-05931
- EX-A1544
- BDBM50341243
- NSC759658
- s7087
- AKOS024458000
- CCG-269373
- CS-0917
- EBC-220132
- NSC-759658
- GSK2334470?
- NCGC00346836-10
- AC-32824
- AS-16973
- FG172878
- HY-14981
- SMR004703010
- SK2334470
- G7344
- SW219485-1
- T2348
- C71892
Look up GSK-2334470 in the interactive SynDRA portal →